Supplemental material
Expert Review of Vaccines
Volume 21, 2022 - Issue 5
Open access
4,877
Views
9
CrossRef citations to date
0
Altmetric
Perspective
Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease
Muhamed-Kheir Tahaa Institut Pasteur, Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenza, Paris, Francehttps://orcid.org/0000-0002-0716-3174
, Federico Martinon-Torresb Genetics, Vaccines, Infectious Diseases, Pediatrics Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela, Galicia, Spain;c Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain;d Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER-ES), Madrid, Spainhttps://orcid.org/0000-0002-9023-581X
, Ralph Köllgese Praxis für Kinder und Jugendliche, Ralph Köllges und Partner, Mönchengladbach, Germanyhttps://orcid.org/0000-0002-7603-7139
, Paolo Bonannif Department of Health Sciences, University of Florence, Florence, Italyhttps://orcid.org/0000-0003-2875-3744
, Marco Aurelio Palazzi Safadig Department of Pediatrics, Santa Casa de São Paulo School of Medical Sciences, Sao Paulo, Brazilhttps://orcid.org/0000-0002-4401-9446
, Robert Booyh Department of Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia;i Sydney Institute of Infectious Diseases, University of Sydney, Sydney, NSW, Australiahttps://orcid.org/0000-0002-1953-7452
, Vinny Smithj Meningitis Research Foundation, Bristol, UKhttps://orcid.org/0000-0001-6127-1435
, Stéphanie Garciak Value Evidence and Outcomes Neisseria, GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-2333-9504
, Rafik Bekkat-Berkanil Global Medical Affairs Neisseria, GSK, Rockville, MD, United Stateshttps://orcid.org/0000-0003-0683-6055
& Véronique Abitbolm Global Medical Affairs Neisseria, GSK, Rueil-Malmaison, FranceCorrespondence[email protected]
https://orcid.org/0000-0003-0369-7715
show allhttps://orcid.org/0000-0003-0369-7715
Pages 659-674
|
Received 24 Jan 2022, Accepted 08 Mar 2022, Published online: 29 Mar 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.